Concepedia

Craig C. Correll

CC

18

Publications

2.1K

Citations

15

H-Index

1997

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

California Institute of Technology

LabCorp (United States)

Craig C. Correll is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and signal transduction.

Top concepts

Publications per year

1997–2020

18

Publications

18

A Complex of Cdc4p, Skp1p, and Cdc53p/Cullin Catalyzes Ubiquitination of the Phosphorylated CDK Inhibitor Sic1p

R. M. Renny Feldman, Craig C. Correll, Kenneth B. Kaplan et al. · Cell · 1997 · 809 citations · Full text

, , +8

Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34

Jaeho Seol, R. M. Renny Feldman, Wolfgang Zachariae et al. · Genes & Development · 1999 · 407 citations · Full text

Functional TRPV4 channels are expressed in human airway smooth muscle cells

Yanlin Jia, Xin Wang, LoriAnn M Varty et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2004 · 179 citations

Human CUL1 forms an evolutionarily conserved ubiquitin ligase complex (SCF) with SKP1 and an F-box protein

Svetlana Lyapina, Craig C. Correll, Edward T. Kipreos et al. · Proceedings of the National Academy of Sciences · 1998 · 139 citations · Full text

Cloning and pharmacological characterization of mouse TRPV1

Craig C. Correll, P. Tara Phelps, John C. Anthes et al. · Neuroscience Letters · 2004 · 110 citations

, ,

Rows per page

1–5 of 18